Goldman Sachs
DMTX

Goldman Sachs’s Dimension Therapeutics, Inc DMTX Stock Holding History

Goldman Sachs’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-80,471
Closed -$117K – 7153
2017
Q2 		$117K Buy
80,471
+54,231
+207% +$73.7K ﹤0.01% 6059
2017
Q1 		$46K Buy
26,240
+6,390
+32% +$16.9K ﹤0.01% 6314
2016
Q4 		$86K Sell
19,850
-1,049
-5% -$5.58K ﹤0.01% 6209
2016
Q3 		$167K Sell
20,899
-75,823
-78% -$548K ﹤0.01% 5944
2016
Q2 		$580K Buy
+96,722
New +$736K ﹤0.01% 4717
2016
Q1 		– Sell
-108,945
Closed -$1.23M – 7687
2015
Q4 		$1.23M Buy
+108,945
New +$1.38M ﹤0.01% 4093

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return